Bacterial Translocation: Microbiota-Intestine-Lung Axis and Pro-Inflammatory Status in the severity of Covid-19

dc.contributor.authorValero-Cedeño, Nereida
dc.contributor.authorÁlava, Danna
dc.contributor.authorRodríguez, Ronny
dc.contributor.authorChacín, Maricarmen
dc.contributor.authorCabrera-Hernández, Maritza
dc.contributor.authorVéliz-Castro, Teresa
dc.contributor.authorCarrero, Yenddy
dc.contributor.authorBermúdez, Valmore
dc.contributor.authorRodriguez-Morales, Alfonso J.
dc.contributor.authorDhawan, Manish
dc.contributor.authorTiwari, Ruchi
dc.contributor.authorDhama, Kuldeep
dc.description.abstractAlthough severe acute respiratory syndrome coronavirus – 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19) pandemic, is primarily associated with a respiratory infection, it has also been linked to multisystem involvement that includes the digestive tract. Gastrointestinal (GI) manifestations are common in patients with COVID-19 due to the high viral load lodged in the small intestine's mucosa. As a result, it causes an increase in the permeability of the intestinal barrier that favours the passage and translocation of bacteria, from the lumen of the intestine, towards the internal environment, with the appearance of sepsis, with evidence that SARS-CoV-2 has been found in faeces. This article highlights epidemiology, clinical symptoms, and mechanisms related to manifestations of disease in the GI tract and its pathogenesis in patients with COVID-19. It highlights bacterial translocation and COVID 19, mechanisms that control bacterial translocation, intestinal infection and feco-oral transmission, defense mechanisms against microbial invasion, role of microbiota/microbiome and implications of their dysbiosis and alterations during SARS-CoV-2 infection, and lastly protective health benefits by improving dietary habits with nutritional foods approaches amid the ongoing pandemic. Increasing evidence indicates that bacterial translocation appears due to the high viral load of COVID-19 in the mucosa of the GI tract, and the intestinal microbiota contributes to the COVID-19 course owing to their bidirectional relationship with the immune system and lungs. Dysbiosis in gut microbiota leads to increased gut permeability thus predisposing to secondary infection and multiple organ dysfunction. Disruption of intestinal barrier integrity due to dysbiosis may cause translocation of SARS-CoV-2 from lungs into the intestinal lumen via the circulatory and lymphatic system, initiating severe clinical presentation of the infection. A thorough understanding of the key role of gut microbiota, gastrointestinal symptoms, and pathology along with immunomodulatory approaches would help in alleviating morbidity and mortality during the ongoing COVID-19 pandemic.eng
dc.publisherHorizon Publisher Indiaeng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.sourceJournal of Experimental Biology and Agricultural Scienceseng
dc.sourceVol. 9 N° 3 (2021)
dc.subjectBacterial translocationeng
dc.subjectGastrointestinal tracteng
dc.titleBacterial Translocation: Microbiota-Intestine-Lung Axis and Pro-Inflammatory Status in the severity of Covid-19eng
dc.type.spaArtículo científicospa
dcterms.referencesAcevedo J (2015) Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies. World Journal of Hepatology 7(7):916. DOI: 10.4254 / wjh.v7.i7.916.eng
dcterms.referencesAcosta Escribano J, Rodríguez Montes J (2007) Importanciaclínica de la translocaciónbacteriana. Nutrición Hospitalaria 22 (Suppl 2): 50-55. Disponible en: arttext &pid =S0212-16112007000500007&lng=es.eng
dcterms.referencesAhmadi Badi S, Tarashi S, Fateh A, Rohani P, Masotti A, Siadat SD (2021) From the role of microbiota in gut-lung axis to SARSCoV-2 pathogenesis. Mediators of Inflammation 2021:6611222.eng
dcterms.referencesAlkhatib A (2020) Antiviral functional foods and exercise lifestyle prevention of coronavirus. Nutrients 12: 2633;. doi:10.3390/ nu12092633.eng
dcterms.referencesAlshukry A, Ali H, Ali Y, Al-Taweel T, Abu-Farha M, AbuBaker J, Devarajan S, Dashti AA, Bandar A, Taleb H, Al Bader A, Aly NY, Al-Ozairi E, Al-Mulla F, Bu Abbas M (2020) Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait. PLoS ONE 15(11): e0242768. Doi: 10.1371/journal.pone.0242768eng
dcterms.referencesAnand AV, Balamuralikrishnan B, Kaviya M, Bharathi K, Parithathvi A, Arun M, Senthilkumar N, Velayuthaprabhu S, Saradhadevi M, Al-Dhabi NA, Arasu MV, Yatoo MI, Tiwari R, Dhama K (2021) Medicinal plants, phytochemicals, and herbs to combat viral pathogens including SARS-CoV-2. Molecules 26(6):1775. DOI: 10.3390/molecules26061775.eng
dcterms.referencesArumugam VA, Thangavelu S, Fathah Z, Ravindran P, Sanjeev AMA, Babu S, Meyyazhagan A, Yatoo MI, Sharun K, Tiwari R, Pandey MK, Sah R, Chandra R, Dhama K (2020) COVID-19, and the world with co-morbidities of heart disease, hypertension, and diabetes. Journal of Pure and Applied Microbiology 14(3):1623- 1638. DOI: 10.22207/JPAM.14.3.01.eng
dcterms.referencesBarriga J, Bohórquez N, Bonifaz V, Castillo V, Cazho L, Díaz D, Herrera E, Longo N, Orozco G, Zambrano M (2020) Guía nutricional para Covid-19. Guía nutricional. Quito - Ecuador: OMS, centro clínico quirúrgico Hospital del día el Batán. Available at: D-19%20%281%29.pdf access on 5th May 2021spa
dcterms.referencesBaud D, Dimopoulou Agri V, Gibson GR, Reid G, Giannoni E (2020) Using probiotics to flatten the curve of Coronavirus Disease COVID-2019 pandemic. Frontiers in Public Health 8:186. Doi: 10.3389/fpubh.2020.00186eng
dcterms.referencesBelkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157(1):121-41. DOI: 10.1016/j.cell.2014.03.011.eng
dcterms.referencesBelouzard S, Millet JK, Licitra BN, Whittaker GR (2012) Mechanisms of corona virus cell entry mediated by the viral spike protein. Viruses 4(6):1011-33. Doi: 10.3390/v4061011.eng
dcterms.referencesBerg RD (1995) Bacterial translocation from the gastrointestinal tract. Trends in Microbiology 3(4):149-54. Doi: 10.1016/s0966- 842x(00)88906-4eng
dcterms.referencesCampanella V, Syed J, Santacroce L, Saini R, Ballini A, Inchingolo F (2018) Oral probiotics influence oral and respiratory tract infections in the pediatric population: a randomized doubleblinded placebo-controlled pilot study. European Review for Medical and Pharmacological Sciences 22(22): 8034-8041. doi:10.26355/eurrev_201811_16433eng
dcterms.referencesCano F, Gajardo M, Freundlich M (2020) Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus. Revista Chilena de Pediatría 91(3): 330-338. DOI:
dcterms.referencesCapodice JL, Chubak BM (2021) Traditional Chinese herbal medicine-potential therapeutic application for the treatment of COVID-19. Chinese Medicine 16(1):24. DOI: 10.1186/s13020- 020-00419-6eng
dcterms.referencesCardinale V, Capurso G, Ianiro G, Gasbarrini A, Arcidiacono PG, Alvaro D (2020) Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Digestive and Liver Disease S1590-8658(20)30469-2. DOI: 10.1016/ j.dld.2020.09.009.eng
dcterms.referencesChen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, Warnke C (2021) A systematic review of neurological symptoms and complications of COVID-19. The Journal of Neurology 268(2):392-402. DOI: 10.1007/s00415-020- 10067-3.eng
dcterms.referencesCiornei RT (2020) Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories. Frontiers in Immunology 11:1762. DOI: 10.3389/fimmu.2020.01762.eng
dcterms.referencesCorradi F, Brusasco C, Fernández J, Vila J, Ramirez MJ, SevaPereira T, Fernández-Varo G, Mosbah IB, Acevedo J, Silva A, Rocco PR, Pelosi P, Gines P, Navasa M (2012) Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites. Digestive and Liver Disease 44(3):239-244. Doi: 10.1016/j.dld.2011.10.014.eng
dcterms.referencesCuicchi D, Lazzarotto T, Poggioli G (2021) Fecal-oral transmission of SARS-CoV-2: review of laboratory-confirmed virus in gastrointestinal system. International Journal of Colorectal Disease 36(3):437-444. DOI: 10.1007/s00384-020-03785-7.eng
dcterms.referencesD'Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L (2020) Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. Clinical Gastroenterology and Hepatology 18(8):1663-1672. DOI: 10.1016/j.cgh.2020.04.001.eng
dcterms.referencesde Faria Coelho-Ravagnani C, Corgosinho FC, Sanches FFZ, Prado CMM, Laviano A, Mota JF (2021) Dietary recommendations during the COVID-19 pandemic. Nutrition Reviews 79(4):382-393. DOI: 10.1093/nutrit/nuaa067eng
dcterms.referencesDerosa L, Melenotte C, Griscelli F, Gachot B, Marabelle A, Kroemer G, Zitvogel L (2020) The immuno-oncological challenge of COVID-19. Nature Cancer 1:946–964 s43018-020-00122-3.eng
dcterms.referencesDhama K, Karthik K, Khandia R, Munjal A, Tiwari R, Rana R, Khurana SK, Sana Ullah, Khan RU, Alagawany M, Farag MR, Dadar M, Joshi SK (2018) Medicinal and therapeutic potential of herbs and plant metabolites/extracts countering viral pathogens - Current knowledge and future prospects. Current Drug Metabolism 19(3):236-263. DOI: 10.2174/1389200219666180129145252.eng
dcterms.referencesDhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020a) Coronavirus Disease 2019-COVID-19. Clinical Microbiology Reviews 33(4): e00028-20.eng
dcterms.referencesDhama K, Latheef SK, Munjal AK, Khandia R, Samad HA, Iqbal HMN, Joshi SK (2017) Probiotics in Curing Allergic and Inflammatory Conditions - Research Progress and Futuristic Vision. Recent Pat Inflamm Allergy Drug Discovery 10(2):105- 118. DOI: 10.2174/1872213X10666161226162229.eng
dcterms.referencesDhama K, Patel SK, Pathak M, Yatoo MI, Tiwari R, Malik YS, Singh R, Sah R, Rabaan AA, Bonilla-Aldana DK, RodriguezMorales AJ (2020b) An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Medicine and Infectious Disease 37:101755. DOI: 10.1016/j.tmaid.2020.101755.eng
dcterms.referencesDhar D, Mohanty A (2020) Gut microbiota and Covid-19- possible link and implications. Virus Research 285:198018. doi:10.1016/j.virusres.2020.198018.eng
dcterms.referencesDhawan M, Parmar M, Sharun K, Tiwari R, Bilal M, Dhama K (2021) Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19. Journal of Applied Pharmaceutical Science 11(04):006–013.eng
dcterms.referencesEl-Ebiary Alarcón M (1994) Es la traslocación bacteriana un mecanismo etiopatogénico de la neumonía nosocomial adquirida durante la ventilación mecánica? Archivos de Bronconeumología 30(4): 228. DOI:
dcterms.referencesEuropean Centre for Disease Prevention and Control (2020) Covid-19 situation update worldwide, as of 31 october 2020, European centre for disease prevention and control (ECDC). Avalilable at 2019-ncov-cases access on 29th April 2021.eng
dcterms.referencesFarré R, Fiorani M, Abdu Rahiman S, Matteoli G (2020) Intestinal Permeability, Inflammation and the Role of Nutrients. Nutrients 12(4):1185. DOI: 10.3390/nu12041185.eng
dcterms.referencesFu Y, Cheng Y, Wu Y (2020) Understanding SARS-CoV-2- Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools. Virologica Sinica 35(3):266-271. DOI:10.1007/s12250-020-00207-4.eng
dcterms.referencesGasmi A, Tippairote T, Mujawdiya PK, Peana M, Menzel A, Dadar M, Benahmed AG, Bjørklund G (2021) The microbiota-mediated dietary and nutritional interventions for COVID-19. Clinical Immunology 226:108725. DOI: 10.1016/j.clim.2021.108725.eng
dcterms.referencesGu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, Li L (2020) Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza. Clinical Infectious Diseases 71(10):2669-2678. doi:10.1093/cid/
dcterms.referencesGulati A, Pomeranz C, Qamar Z, Thomas S, Frisch D, George G, Summer R, DeSimone J, Sundaram B (2020) A comprehensive review of manifestations of novel Coronaviruses in the context of deadly COVID-19 global pandemic. American Journal of the Medical Sciences 360(1):5-34. doi: 10.1016/j.amjms.2020.05.006eng
dcterms.referencesGuo M, Tao W, Flavell RA, Zhu S (2021) Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nature Reviews Gastroenterology & Hepatology 18(4):269-283. doi: 10.1038/s41575-021-00416-6.eng
dcterms.referencesGupta S, Parker J, Smits S, Underwood J, Dolwani S (2020) Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review. Colorectal Disease 22(6):611-620. DOI: 10.1111/codi.15138.eng
dcterms.referencesHaiminen N, Utro F, Seabolt E, Parida L (2021) Functional profiling of COVID-19 respiratory tract microbiomes. Scientific Reports 11(1):6433. doi: 10.1038/s41598-021-85750-0.eng
dcterms.referencesHamming I, Timens W, Bulthuis ML, Lely AT, Navis GJ, and Van GH (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Journal of Pathology 203:631–637. Doi:10.1002/path.1570eng
dcterms.referencesHindson J (2020) COVID-19: faecal-oral transmission? Nature Reviews Gastroenterology & Hepatology 17(5):259. DOI: 10.1038/s41575-020-0295-7.eng
dcterms.referencesHoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271-280.e8. DOI: 10.1016/j.cell.2020.02.052.eng
dcterms.referencesIddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, Bohn T (2020) Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: Considerations during the COVID-19 Crisis. Nutrients 12(6):1562.
dcterms.referencesInfante Velázquez M (2020) Implicaciones de la infección por el nuevo coronavirus SARS-CoV-2 para el sistema digestivo. Arch Cuba gastroenterol 1(2). Disponible en: index.php/gast/article/view/38.eng
dcterms.referencesInfusino F, Marazzato M, Mancone M, Fedele F, Mastroianni CM, Severino P, d'Ettorre G (2020) Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: A scoping review. Nutrients 12(6). DOI:10.3390/nu12061718.eng
dcterms.referencesJin B, Singh R, Ha SE, Zogg H, Park PJ, Ro S (2021) Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World Journal of Gastroenterology 27(19):2341-2352. DOI: 10.3748/wjg.v27.i19.2341eng
dcterms.referencesKullar R, Johnson S, McFarland LV, Goldstein EJC (2021) Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use. Antibiotics (Basel)10(4):408. doi: 10.3390/antibiotics10040408.eng
dcterms.referencesKurian SJ, Unnikrishnan MK, Miraj SS, Bagchi D, Banerjee M, Reddy BS, Rodrigues GS, Manu MK, Saravu K, Mukhopadhyay C, Rao M (2021) Probiotics in prevention and treatment of COVID-19: Current perspective and future prospects. Archives of Medical Research S0188-4409(21)00047-3. DOI: 10.1016/ j.arcmed.2021.03.002.eng
dcterms.referencesLee NK, Paik HD (2021) Prophylactic effects of probiotics on respiratory viruses including COVID-19: a review. Food Science and Biotechnology 24:1-9. doi: 10.1007/s10068-021-00913-z.eng
dcterms.referencesLi LY, Wu W, Chen S, Gu JW, Li XL, Song HJ, Du F, Wang G, Zhong CQ, Wang XY, Chen Y, Shah R, Yang HM, Cai Q (2020) Digestive system involvement of novel coronavirus infection: Prevention and control infection from a gastroenterology perspective. Journal of Digestive Diseases 21(4): 199–204.
dcterms.referencesLozada-Requena I, Núñez Ponce C (2020) COVID-19: respuesta inmune y perspectivas terapéuticas. Revista Peruana de Medicina Experimental y SaludPública 37(2). DOI:
dcterms.referencesLu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, et al. (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565-574. DOI:10.1016/S0140-6736(20)30251-8.eng
dcterms.referencesLucas JM, Heinlein C, Kim T, Hernandez SA, Malik MS, True LD, Morrissey C, Corey E, Montgomery B, Mostaghel E, Clegg N, Coleman I, Brown CM, Schneider EL, Craik C, Simon JA, Bedalov A, Nelson PS (2014) The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Cancer Discovery 4(11):1310-1325. DOI: 10.1158/2159-8290.CD-13-1010eng
dcterms.referencesMarchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A (2016). The gut microbiota and host health: a new clinical frontier. Gut 65(2): 330-339. doi:10.1136/gutjnl-2015-309990eng
dcterms.referencesMathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, et al. (2020) Deep immune profiling of COVID19 patients reveals distinct immunotypes with therapeutic implications. Science 369(6508):eabc8511. doi: 10.1126/science.abc8511eng
dcterms.referencesMeng X, Lou QY, Yang WY, Chen R, Xu WH, Yang Y, Zhang L, Xu T, Xiang HF (2021) Gordian Knot: Gastrointestinal lesions caused by three highly pathogenic coronaviruses from SARS-CoV and MERS-CoV to SARS-CoV-2. European Journal of Pharmacology 2021 Jan 5;890:173659. doi: 10.1016/j.ejphar.2020.173659eng
dcterms.referencesMinistry of Health (MH, Spain) (2020) España. Información científico-técnica. Enfermedad por coronavirus, COVID-19. Centro de Coordinación de Alertas y Emergencias Sanitarias. Disponible en: sActual/nCov/documentos/ITCoronavirus.pdfeng
dcterms.referencesMunster VJ, Koopmans M, Van Doremalen N, Van Riel D, de Wit E (2020) A Novel Coronavirus emerging in China - Key questions for impact assessment. New England Journal of Medicine 382(8):692-694. DOI: 10.1056/NEJMp2000929.eng
dcterms.referencesNarasimhan H, Ren CC, Deshpande S, Sylvia KE (2021) Young at gut-turning back the clock with the gut microbiome. Microorganisms 9(3):555. doi: 10.3390/microorganisms9030555.eng
dcterms.referencesNishiga M, Wang DW, Han Y, Lewis DB, Wu JC (2020) COVID19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology 17(9):543-558. doi: 10.1038/s41569-020-0413-9eng
dcterms.referencesO'Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC (1998) Microbiology of bacterial translocation in humans. Gut 42(1):29-35. DOI: 10.1136/gut.42.1.29.eng
dcterms.referencesOrtiz-Prado E, Simbaña-Rivera K, Barreno LG, Rubio-Neira M, Guaman LP, Kyriakidis NC, et al. (2020) Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagnostic Microbiology and Infectious Disease 98(1): 115094. DOI:
dcterms.referencesOu X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z, Mu Z, Chen X, Chen J, Hu K, Jin Q, Wang J, Qian Z (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nature Communications 11(1):1620. DOI: 10.1038/s41467-020- 15562-9.eng
dcterms.referencesPaltiel AD, Schwartz JL, Zheng A, Walensky RP (2021) Clinical Outcomes of A COVID-19 Vaccine: Implementation Over Efficacy. Health Affairs (Millwood) 40(1):42-52. DOI: 10.1377/hlthaff.2020.02054.eng
dcterms.referencesPan L, Mu M, Yang P, Sun Y, Wang R, Yan J, Li P, Hu B, Wang J, Hu C, Jin Y, Niu X, Ping R, Du Y, Li T, Xu G, Hu Q, Tu L (2020) Clinical Characteristics of COVID-19 Patients with Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. American Journal of Gastroenterology 115(5):766-773. Doi: 10.14309/ajg.0000000000000620eng
dcterms.referencesPelletier G, Briantais MJ, Buffet C, Pillot J, Etienne JP (1982) Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver. Gut 23(6):475-480. Doi: 10.1136/gut.23.6.475.eng
dcterms.referencesRabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Hasan A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Emran TB, Bilal M, Singh R, Alyami SA, Moni MA, Dhama K (2021c) Diverse immunological factors influencing pathogenesis in patients with COVID-19: A review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses. Pathogens 10:565. https://
dcterms.referencesRabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Al-Omari A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Bilal M, Alyami SA, Emran TB, Moni MA, Dhama K (2021b) Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines (Basel) 9(5):436. doi: 10.3390/vaccines9050436eng
dcterms.referencesRabaan AA, Al-Ahmed SH, Sah R, Alqumber MA, Haque S, Patel SK, Pathak M, Tiwari R, Yatoo MI, Haq AU, Bilal M, Dhama K, Rodriguez-Morales AJ (2021a) MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges. Annals of Clinical Microbiology and Antimicrobials 20(1):8. doi: 10.1186/s12941-020-00414-7.eng
dcterms.referencesRahal A, Mahima, Verma AK, Kumar A, Tiwari R, Kapoor S, Chakraborty S, Dhama K (2014) Phytonutrients and nutraceuticals in vegetables and their multi-dimensional medicinal and health benefits for humans and their companion animals: A review. Journal of Biological Sciences 14(1): 1-19eng
dcterms.referencesRawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A (2020) Bacterial and fungal coinfection in individuals with Coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clinical Infectious Diseases 71(9):2459-2468. Doi: 10.1093/cid/ciaa530.eng
dcterms.referencesRunyon BA, Squier S, Borzio M (1994) Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. Journal of Hepatology 21(5):792-6. DOI: 10.1016 / s0168-8278 (94) 80241-6.eng
dcterms.referencesSaleh J, Peyssonnaux C, Singh KK, Edeas M (2020) Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion 54:1-7. doi:10.1016/j.mito.2020.06.008.eng
dcterms.referencesSanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA (2019) Author correction: Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nature Reviews Gastroenterology & Hepatology 16(10): 642. doi:10.1038/s41575- 019-0199-6eng
dcterms.referencesScarpellini E, Ianiro G, Attili F, Bassanelli C, De Santis A, Gasbarrini A (2015) The human gut microbiota and virome: Potential therapeutic implications. Digestive and Liver Disease 47(12): 1007-1012. doi:10.1016/j.dld.2015.07.008eng
dcterms.referencesSokolowska M, Lukasik ZM, Agache I, Akdis CA, Akdis D, Akdis M, Barcik W, Brough HA, et al. (2020) Immunology of COVID19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy 75(10):2445-2476. Doi: 10.1111/all.14462.eng
dcterms.referencesSolà R, Soriano G (2002) Why do bacteria reach ascitic fluid? European Journal of Gastroenterology & Hepatology 14(4):351- 354. Doi: 10.1097/00042737-200204000-00002.eng
dcterms.referencesSoriano G, Guarner C (2003) Prevención de la translocación bacteriana mediante probióticos y prebióticos. Gastroenterology & Hepatology 26 (Supl 1): 23-3.eng
dcterms.referencesSteffen EK, Berg RD, Deitch EA (1988) Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. Journal of Infectious Diseases 157(5):1032-1038. DOI: 10.1093/infdis/157.5.1032.eng
dcterms.referencesSundararaman A, Ray M, Ravindra PV, Halami PM (2020) Role of probiotics to combat viral infections with emphasis on COVID-19. Applied Microbiology and Biotechnology 104(19): 8089-8104. doi:10.1007/s00253-020-10832-4.eng
dcterms.referencesTeo S, Walker A, Steer A (2013) Spontaneous bacterial peritonitis as a presenting feature of nephrotic syndrome. Journal of Paediatrics and Child Health 49: 1069-1071. Doi: 10.1111 / jpc.12389.eng
dcterms.referencesThakur V, Ratho RK, Kumar P, Bhatia SK, Bora I, Mohi GK, Saxena SK, Devi M, Yadav D, Mehariya S (2021) Multi-organ involvement in COVID-19: beyond pulmonary manifestations. Journal of Clinical Medicine10(3): 446. jcm10030446.eng
dcterms.referencesThirumdas R, Kothakota A, Pandiselvam R, Bahrami A, Barba FJ (2021) Role of food nutrients and supplementation in fighting against viral infections and boosting immunity: A review. Trends in Food Science & Technology 66-77. DOI: 10.1016/j.tifs.2021.01.069eng
dcterms.referencesTian Y, Sun KY, Meng TQ, Ye Z, Guo SM, Li ZM, Xiong CL, Yin Y, Li HG, Zhou LQ (2021) Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery. Frontiers in nutrition 8: 638825. fnut.2021.638825eng
dcterms.referencesTrottein F, Sokol H (2020) Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection. Cell Reports 32(3):107915. doi: 10.1016/j.celrep.2020.107915.eng
dcterms.referencesTufan A, Güler AA, Matucci-Cerinic M (2020) COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turkish Journal of Medical sciences 50(3): 620–632.eng
dcterms.referencesValero Nereida, Larreal Yraima, Mosquera Jesús, Rincón Enrique (2005) Síndrome Respiratorio Agudo Severo (SRAS): Lecciones y Retos. Journal of Clinical Investigation 46(1):75-95. Disponible en: 51332005000100009&lng=es.eng
dcterms.referencesValero-Cedeño NJ, Mina-Ortiz JB, Veliz-Castro TI, MerchánVillafuerte KM, Perozo-Mena AJ (2020) COVID-19: La nueva pandemia con muchas lecciones y nuevos retos. Revisión Narrativa. Kasmera 48(1): e48102042020. DOI: 10.5281/
dcterms.referencesVan Leeuwen PA, Boermeester MA, Houdijk AP, Ferwerda CC, Cuesta MA, Meyer S, Wesdorp RI (1994) Clinical significance of translocation. Gut 35(1 Suppl): S28-34. Doi: 10.1136/gut.35.1_suppl.s28.eng
dcterms.referencesWadman M, Couzin-Frankel J, Kaiser J, Matacic C (2020) A rampage through the body. Science 368(6489):356-360. doi: 10.1126/science.368.6489.356.eng
dcterms.referencesWalls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, Function, and Antigenicity of the SARS-CoV2 Spike Glycoprotein. Cell 181(2):281-292. e6. DOI: 10.1016/j.cell.2020.02.058.eng
dcterms.referencesWalsh KA, Jordan K, Clyne B, Rohde D, Drummond L, Byrne P, Ahern S, Carty PG, O'Brien KK, O'Murchu E, O'Neill M, Smith SM, Ryan M, Harrington P (2020) SARS-CoV-2 detection, viral load and infectivity over the course of an infection. Journal of Infection 81(3):357-371. DOI: 10.1016/j.jinf.2020.06.067eng
dcterms.referencesWan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology 94:e00127-20. https://doi .org/10.1128/JVI.00127-20.eng
dcterms.referencesWang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W (2020) Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 323(18):1843-1844. doi: 10.1001/jama.2020.3786eng
dcterms.referencesWHO (2021) WHO COVID-19 Dashboard - Up to date data on pandemic. EiwANuR9YM0k0JigJ56NivXbxLo_GNuUC2W0j79EBV9ZLho5 WBFDR7AO8Bt2ihoCqfoQAvD_BwE Accessed on June 2, 2021.eng
dcterms.referencesWölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C, Hoelscher M, Bleicker T, Brünink S, Schneider J, Ehmann R, Zwirglmaier K, Drosten C, Wendtner C (2020) Virological assessment of hospitalized patients with COVID-2019. Nature 581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1. Erratum in: Nature. 2020 Dec;588(7839):E35.eng
dcterms.referencesWong SH, Lui RN, Sung JJ (2020) Covid-19 and the digestive system. Journal of gastroenterology and hepatology, 35(5): 744– 748. DOI:
dcterms.referencesWorld Health Organization (2020a) Coronavirus. (Online). Available at: coronavirus access on 29th April 2021.eng
dcterms.referencesWorld Health Organization (2020b) Los nombres de la enfermedad por coronavirus (COVID-19) y del virus que la causa. (Online). Available at access on 27 July 2020eng
dcterms.referencesWorld Health Organization (2020c) La administración de suplementos de vitamina A a adultos infectados por el VIH y la progresión de la enfermedad. Available at: access on 29th April 2021.eng
dcterms.referencesWorld Health Organization (2020d) Brote de enfermedad por el Coronavirus (COVID-19) Available at: access on 29th April
dcterms.referencesWorld Health Organization (2020e) WHO Coronavirus Disease (COVID-19) Dashboard. Available at access on 29th April 2021.eng
dcterms.referencesXie M, Chen Q (2020) Insight into 2019 novel coronavirus- An updated interim review and lessons from SARS-CoV and MERSCoV. International Journal of Infectious Disease 94: 119-124. DOI:
dcterms.referencesXu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, Li J, Wang H, Yu L, Huang H, Qiu Y, Wei G, Fang Q, Zhou J, Sheng J, Liang T, Li L (2020a) Management of corona virus disease-19 (COVID-19): The Zhejiang experience. Journal of Zhejiang University. Medical Sciences 49(1):147-157. DOI: 10.3785/j.issn.1008-9292.2020.02.02eng
dcterms.referencesXu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, Guo Q, Sun X, Zhao D, Shen J, Zhang H, Liu H, Xia H, Tang J, Zhang K, Gong S (2020b) Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nature Medicine 26(4):502-505. DOI: 10.1038/s41591-020-0817-4eng
dcterms.referencesYang Y, Huang W, Fan Y, Chen GQ (2021) Gastrointestinal microenvironment and the gut-lung axis in the immune responses of severe COVID-19. Frontiers in Molecular Biosciences 8:647508. DOI: 10.3389/fmolb.2021.647508.eng
dcterms.referencesYoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI (2020) Gut microbiota and immune system interactions. Microorganisms. 8(10):1587. doi: 10.3390/microorganisms8101587. Erratum in: Microorganisms 8(12): PMID: 33076307; PMCID: PMC7602490eng
dcterms.referencesYuan C, Wang H, Li K, Tang A, Dai Y, Wu B, Zhang H, Chen J, Liu J, Wu W, Gu S, Wang H, Xu H, Wu M, Yu M, Wang Y, Yu X, He J, Liu S, Zhang Y, Tong Z, Yan J (2021) SARS-CoV-2 viral shedding characteristics and potential evidence for the priority for faecal specimen testing in diagnosis. PLoS One 16(2):e0247367. doi: 10.1371/journal.pone.0247367.eng
dcterms.referencesYusuf F, Fahriani M, Mamada SS, et al. (2021) Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis [version 1; peer review: 2 approved]. F1000Research 10:301 (
dcterms.referencesZang R, Gomez Castro MF, McCune BT, Zeng Q, Rothlauf PW, Sonnek NM, Liu Z, KF, Wang X, Greenberg HB, Diamond MS, Ciorba MA, Whelan SPJ, Ding S (2020) TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Science Immunology 5(47):eabc3582. doi: 10.1126/sciimmunol.abc3582eng
dcterms.referencesZhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, Li Z, Cui X, Xiao J, Zhan J, Meng T, Zhou W, Liu J, Xu H. (2020) Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut 69(6):1010–1018. doi: 10.1136/gutjnl-2020-320953eng
dcterms.referencesZhang J, Dong W (2020) Expression of B cell translocation gene 1 protein in colon carcinoma and its clinical significance. Recent Patents on Anti-Cancer Drug Discovery 15(1):78-85. doi:10.2174/1574892815666200109113114.eng
dcterms.referencesZhang Y, Cen M, Hu M, Du L, Hu W, Kim JJ, Dai N (2021) Prevalence and persistent shedding of fecal SARS-CoV-2 RNA in patients with COVID-19 infection: A systematic review and metaanalysis. Clinical and Translational Gastroenterology 12(4):e00343. DOI: 10.14309/ctg.0000000000000343.eng
dcterms.referencesZhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y (2020) COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduction and Targeted Therapy 5(1):256. DOI: 10.1038/s41392-020-00373-7.eng
dcterms.referencesZuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, Lai CKC, Chen Z, Tso EYK, Fung KSC, Chan V, Ling L, Joynt G, Hui DSC, Chan FKL, Chan PKS, Ng SC (2020) Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159(3):944-955.e8. DOI: 10.1053/j.gastro.2020.05.048.eng


Bloque original
Mostrando 1 - 1 de 1
457.79 KB
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
381 B
Item-specific license agreed upon to submission